Therapeutics · Ovulation Agents

Evaluation of a new ovulatory stimulating agent: clomiphene citrate (clomid)

No Authors Listed

Published October 14, 1968 JAMA, 206(3), 635-636
DOI 10.1001/jama.1968.03150030091021 PMID 5695585

Abstract

Clomiphene citrate, in selected patients, is an effective agent for the treatment of infertility due to anovulation. An adequate laboratory and physical evaluation of each individual patient is essential for proper use of the drug. The major adverse reactions encountered are ovarian enlargements and cysts; in most patients, these conditions regress spontaneously after withdrawal of the drug.

Topics

By this author

Related research

Therapeutics › Ovulation Agents › Selective Estrogen Receptor Modulators · Menstrual Cycle › Cycle Disorders › Ovulatory Disturbances
PMID 5695585 5695585 DOI 10.1001/jama.1968.03150030091021 10.1001/jama.1968.03150030091021 No Authors Listed et al. 1968, No Authors Listed 1968

Cite this article

No Authors Listed (1968). Evaluation of a new ovulatory stimulating agent: clomiphene citrate (clomid). JAMA, 206(3), 635-636. https://doi.org/10.1001/jama.1968.03150030091021